Breast Recurrence Score Test Market Size, Share, and Growth Forecast for 2025 - 2032

Breast Recurrence Score Test Market by Product (Test Kits, Reagents & Consumables) Indication (Stage 1 Breast Cancer, Stage 2 Breast Cancer, Estrogen-Receptor-Positive Cancer, Lymph-Node-Negative Cancer), End User (Hospitals, Specialty Cancer Centers, Diagnostic Centers, Cancer Research Institutions) and Regional Analysis

Industry: Healthcare

Published Date: March-2025

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 233

Report ID: PMRREP32146

Report Price

$4995*

Buy Now

Table of Content

  1. Executive Summary
    1. Global Breast Recurrence Score Test Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2024 – 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Product Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Global Breast Recurrence Score Test Market Outlook
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2023
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2024 – 2032
    3. Global Breast Recurrence Score Test Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 – 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 – 2032
        1. Test Kits
        2. Reagents & Consumables
      4. Market Attractiveness Analysis: Product
    4. Global Breast Recurrence Score Test Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By Indication, 2019 – 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 – 2032
        1. Stage 1 Breast Cancer
        2. Stage 2 Breast Cancer
        3. Estrogen-Receptor-Positive Cancer
        4. Lymph-Node-Negative Cancer
      4. Market Attractiveness Analysis: Indication
    5. Global Breast Recurrence Score Test Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 – 2023
      3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 – 2032
        1. Hospitals
        2. Specialty Cancer Centers
        3. Diagnostic Centers
        4. Cancer Research Institutions
      4. Market Attractiveness Analysis: End User
  5. Global Breast Recurrence Score Test Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 – 2023
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024 – 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Breast Recurrence Score Test Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 – 2032
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 – 2032
      1. Test Kits
      2. Reagents & Consumables
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 – 2032
      1. Stage 1 Breast Cancer
      2. Stage 2 Breast Cancer
      3. Estrogen-Receptor-Positive Cancer
      4. Lymph-Node-Negative Cancer
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 – 2032
      1. Hospitals
      2. Specialty Cancer Centers
      3. Diagnostic Centers
      4. Cancer Research Institutions
    7. Market Attractiveness Analysis
  7. Europe Breast Recurrence Score Test Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 – 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 – 2032
      1. Test Kits
      2. Reagents & Consumables
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 – 2032
      1. Stage 1 Breast Cancer
      2. Stage 2 Breast Cancer
      3. Estrogen-Receptor-Positive Cancer
      4. Lymph-Node-Negative Cancer
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 – 2032
      1. Hospitals
      2. Specialty Cancer Centers
      3. Diagnostic Centers
      4. Cancer Research Institutions
    7. Market Attractiveness Analysis
  8. East Asia Breast Recurrence Score Test Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 – 2032
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 – 2032
      1. Test Kits
      2. Reagents & Consumables
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 – 2032
      1. Stage 1 Breast Cancer
      2. Stage 2 Breast Cancer
      3. Estrogen-Receptor-Positive Cancer
      4. Lymph-Node-Negative Cancer
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 – 2032
      1. Hospitals
      2. Specialty Cancer Centers
      3. Diagnostic Centers
      4. Cancer Research Institutions
    7. Market Attractiveness Analysis
  9. South Asia & Oceania Breast Recurrence Score Test Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 – 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 – 2032
      1. Test Kits
      2. Reagents & Consumables
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 – 2032
      1. Stage 1 Breast Cancer
      2. Stage 2 Breast Cancer
      3. Estrogen-Receptor-Positive Cancer
      4. Lymph-Node-Negative Cancer
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 – 2032
      1. Hospitals
      2. Specialty Cancer Centers
      3. Diagnostic Centers
      4. Cancer Research Institutions
    7. Market Attractiveness Analysis
  10. Latin America Breast Recurrence Score Test Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 – 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 – 2032
      1. Test Kits
      2. Reagents & Consumables
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 – 2032
      1. Stage 1 Breast Cancer
      2. Stage 2 Breast Cancer
      3. Estrogen-Receptor-Positive Cancer
      4. Lymph-Node-Negative Cancer
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 – 2032
      1. Hospitals
      2. Specialty Cancer Centers
      3. Diagnostic Centers
      4. Cancer Research Institutions
    7. Market Attractiveness Analysis
  11. Middle East & Africa Breast Recurrence Score Test Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2023
      1. By Country
      2. By Product
      3. By Indication
      4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024 – 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024 – 2032
      1. Test Kits
      2. Reagents & Consumables
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024 – 2032
      1. Stage 1 Breast Cancer
      2. Stage 2 Breast Cancer
      3. Estrogen-Receptor-Positive Cancer
      4. Lymph-Node-Negative Cancer
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024 – 2032
      1. Hospitals
      2. Specialty Cancer Centers
      3. Diagnostic Centers
      4. Cancer Research Institutions
    7. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. ThermoFisher Scientific
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Exact Sciences (Genome Health Inc.)
      3. NanoString Technologies, Inc.
      4. Foundation Medicine, Inc
      5. Illumina, Inc
      6. Hologic Inc (Biotheranostic)
      7. Biocartis
      8. Roche Diagnostics
      9. Epic Sciences
      10. Qiagen
      11. Abbott
      12. Myriad Genetics, Inc
      13. Guardant Health
      14. Agendia
      15. Genomic Health
      16. iCAD
      17. CancerIQ
      18. Siemens Healthineers
      19. General Electric Company
      20. Koninklijke Philips NV
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate